Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
vaginal microbiota transplant (Johns Hopkins University)
- Development stage
- Unknown
- Lead developer
- Johns Hopkins University
- Modality
- Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Vaginal
01
Overview
Vaginal microbiota transplant (VMT) is an investigational live biotherapeutic therapy being developed by Johns Hopkins University for the treatment of recurrent bacterial vaginosis (BV). The therapy involves the transfer of cervicovaginal secretions from a healthy, screened donor to a recipient with BV. The goal is to restore a healthy, Lactobacillus-dominant vaginal microbiome, thereby displacing the polymicrobial community characteristic of BV. [2, 7] The VMT-01 Phase 1 clinical trial was designed to evaluate the safety and efficacy of this approach, where a single dose of the transplant material is administered vaginally after a course of standard antibiotic treatment. [3]
- Other names
- VMTcervicovaginal secretions
Beyond the preview
Go deeper on vaginal microbiota transplant (Johns Hopkins University).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on vaginal microbiota transplant (Johns Hopkins University).